BRUGIA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.239
EU - Europa 1.754
AS - Asia 1.294
SA - Sud America 111
AF - Africa 24
OC - Oceania 17
Totale 5.439
Nazione #
US - Stati Uniti d'America 2.206
RU - Federazione Russa 685
SG - Singapore 386
CN - Cina 372
IT - Italia 333
PL - Polonia 228
HK - Hong Kong 221
IE - Irlanda 121
KR - Corea 111
BR - Brasile 90
SE - Svezia 83
DE - Germania 80
FI - Finlandia 58
IN - India 50
VN - Vietnam 45
JO - Giordania 41
AT - Austria 38
FR - Francia 38
ID - Indonesia 23
GB - Regno Unito 21
CA - Canada 20
CH - Svizzera 17
AU - Australia 16
NL - Olanda 16
ES - Italia 13
MX - Messico 11
ZA - Sudafrica 11
JP - Giappone 10
AR - Argentina 8
BD - Bangladesh 8
TR - Turchia 8
UA - Ucraina 7
BE - Belgio 5
PK - Pakistan 5
EC - Ecuador 4
IQ - Iraq 4
MA - Marocco 4
BJ - Benin 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
PH - Filippine 3
UZ - Uzbekistan 3
AL - Albania 2
EG - Egitto 2
NO - Norvegia 2
PE - Perù 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
UY - Uruguay 1
Totale 5.439
Città #
Santa Clara 583
Ashburn 318
Singapore 262
Warsaw 223
Hong Kong 188
Chandler 123
Dublin 121
Hefei 113
Seoul 111
Fairfield 100
Florence 96
San Jose 89
Beijing 80
Dallas 52
Seattle 51
Cambridge 49
Houston 49
Los Angeles 46
Woodbridge 45
Munich 43
Buffalo 42
Vienna 37
Wilmington 37
Helsinki 33
Altamura 32
Moscow 32
New York 31
Paris 30
Lawrence 28
The Dalles 28
Ann Arbor 25
Shanghai 25
Boston 21
Bremen 20
Mumbai 20
Princeton 20
Jakarta 19
Milan 19
Turku 19
Kent 18
Bern 17
Melbourne 16
Boardman 14
Rome 14
Medford 12
Pune 12
Clifton 11
Hanoi 11
Ho Chi Minh City 11
São Paulo 11
Tokyo 10
Barcelona 8
Bengaluru 8
Brescia 8
Dong Ket 8
Johannesburg 7
Toronto 7
Atlanta 6
Frankfurt am Main 6
London 6
Bologna 5
Brooklyn 5
Brussels 5
Falls Church 5
Montreal 5
Stockholm 5
Amandola 4
Charlotte 4
Chennai 4
Cinisello Balsamo 4
Denver 4
Hangzhou 4
Lappeenranta 4
Mexico City 4
Naples 4
Orem 4
Phoenix 4
San Diego 4
Yubileyny 4
Abidjan 3
Alba 3
Ancona 3
Ankara 3
Belo Horizonte 3
Cotonou 3
Council Bluffs 3
Hải Dương 3
Istanbul 3
Mykolayiv 3
Olomouc 3
Ottawa 3
Redondo Beach 3
San Marco Evangelista 3
Sesto Fiorentino 3
Shenzhen 3
Siena 3
St Louis 3
Tashkent 3
Tianjin 3
Amsterdam 2
Totale 3.625
Nome #
Emerging drugs in refractory colorectal cancer 314
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 263
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 213
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 209
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 208
Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer. 203
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 190
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 188
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 182
Current status and future perspectives in HER2 positive advanced gastric cancer 179
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 176
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 175
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 173
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 173
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 172
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 172
Physical exercise and eating habits in cancer survivors 169
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 168
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 162
Somatostatin analogs in pregnant patients with neuroendocrine tumor 162
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 160
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 159
Results of the observational prospective RealFLOT study 158
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 155
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 154
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 144
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 142
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 139
Regorafenib also can cause osteonecrosis of the jaw 135
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 132
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 105
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 53
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 13
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS 11
Totale 5.511
Categoria #
all - tutte 16.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 22 15 27 33 20 13
2021/2022138 4 7 5 3 2 10 1 20 11 13 16 46
2022/2023651 32 110 18 60 45 121 70 55 80 9 20 31
2023/2024398 9 25 37 18 20 62 25 81 8 34 34 45
2024/20251.991 63 175 111 330 503 265 30 123 106 74 92 119
2025/20261.602 329 304 245 215 301 94 114 0 0 0 0 0
Totale 5.511